John J Barron
Overview
Explore the profile of John J Barron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barron J, Willey V, Doherty B, Tunceli O, Waltz C, Grabner M, et al.
Pharmacoepidemiol Drug Saf
. 2025 Feb;
34(2):e70110.
PMID: 39909722
Background And Methods: The Healthcare Integrated Research Database (HIRD) is a large, comprehensive real-world data (RWD) source for health-related research. Demographic and healthcare-related characteristics of individuals are sourced from routinely...
2.
Geynisman D, Hill N, Rosenblatt L, Yin X, Haley V, Barron J, et al.
JCO Oncol Pract
. 2025 Jan;
:OP2400564.
PMID: 39761490
Purpose: The treatment landscape for metastatic renal cell carcinoma (mRCC) has evolved in recent years with the use of tyrosine kinase inhibitors (TKIs) and immuno-oncology (IO) therapies. This study examined...
3.
Liu Y, Gordon A, Eleff M, Barron J, Chi W
J Breast Imaging
. 2024 Feb;
5(1):21-29.
PMID: 38416960
Objective: Guidelines for optimal frequency of screening mammography vary by professional society. Sparse evidence exists on the association between screening frequency and breast cancer treatment options. The main objective was...
4.
Kanter G, Parikh R, Fisch M, Debono D, Bekelman J, Xu Y, et al.
JCO Oncol Pract
. 2022 Jul;
18(10):e1672-e1682.
PMID: 35830621
Purpose: The integration of pharmacies with oncology practices-known as medically integrated dispensing or in-office dispensing-could improve care coordination but may incentivize overprescribing or inappropriate prescribing. Because little is known about...
5.
Gunturu K, Pham T, Shambhu S, Fisch M, Barron J, Debono D
Support Care Cancer
. 2022 Jan;
30(5):4019-4026.
PMID: 35064328
Background: Immune checkpoint inhibitors (ICI) are increasingly used across multiple cancer types and stages and little is known about real-world outcomes. This study sought to determine healthcare utilization, costs, immune-related...
6.
Parikh R, Fishman E, Chi W, Zimmerman R, Gupta A, Barron J, et al.
JAMA Oncol
. 2020 Apr;
6(6):839-846.
PMID: 32297905
Importance: Breast cancer accounts for the largest portion of cancer-related spending in the United States. Although hypofractionated radiotherapy after breast-conserving surgery is a cost-effective and convenient treatment strategy for patients...
7.
Fishman E, Fisch M, Liu Y, Barron J, Nguyen A, Sylwestrzak G
JCO Oncol Pract
. 2020 Mar;
16(8):e797-e806.
PMID: 32155109
Purpose: Cancer care has increasingly shifted from physician offices (MDOs) to hospital-based outpatient departments (HOPDs). This study compared the proportion of patients receiving optimal, evidence-based anticancer drug regimens and the...
8.
Charlton B, Adeboyeje G, Barron J, Grady D, Shin J, Redberg R
PLoS One
. 2018 Mar;
13(3):e0193912.
PMID: 29590141
Background: Different outcomes among patients hospitalized for bleeding after starting anticoagulation could influence choice of anticoagulant. We compared length of hospitalization, proportion of Intensive Care Unit (ICU) admissions, ICU length...
9.
Power T, Ke X, Zhao Z, Bonine N, Cziraky M, Grabner M, et al.
Vasc Health Risk Manag
. 2018 Feb;
14:23-36.
PMID: 29440909
Purpose: The aim of this study was to investigate real-world patient characteristics, medication use, and health care resource utilization (HCRU) and costs among patients with clinical atherosclerotic cardiovascular disease (ASCVD)...
10.
Kern D, Barron J, Wu B, Ganetsky A, Willey V, Quimbo R, et al.
Pragmat Obs Res
. 2017 Sep;
8:149-155.
PMID: 28894396
Background: Data from a Cancer Care Quality Program are directly integrated with administrative claims data to provide a level of clinical detail not available in claims-based studies, and referred to...